Concomitant Inhibition of mTORC1 and mTORC2 in Dendritic Cells Reduces SOCS3 Expression Resulting in Enhanced Immunoregulatory PD-L1 Expression and IL-10 Secretion

被引：0
|
作者：
Rosborough, B. R. [1 ,2 ]
Matta, B. M. [1 ,2 ]
Turnquist, H. R. [1 ,2 ]
Thomson, A. [1 ,2 ]
机构：
[1] Univ Pittsburgh, Surg, Pittsburgh, PA USA
[2] Starzl Transplantat Inst, Pittsburgh, PA USA
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00023
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1315
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [1] mTORC2 negatively regulates DC PD-L1 and IL-10 through SOCS3 and STAT3
    Rosborough, Brian
    Matta, Ben
    Turnquist, Heth
    Thomson, Angus
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [2] Inhibition of mTORC1 and 2 in Dendritic Cells Augments PD-L1 Expression and Promotes Their Induction of Regulatory T Cells
    Rosborough, B. R.
    Turnquist, H. R.
    Thomson, A. W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 215 - 215
  • [3] mTORC1 and mTORC2 expression in inner retinal neurons and glial cells
    Losiewicz, Mandy K.
    Elghazi, Lynda
    Fingar, Diane C.
    Rajala, Raju V. S.
    Lentz, Stephen, I
    Fort, Patrice E.
    Abcouwer, Steven F.
    Gardner, Thomas W.
    EXPERIMENTAL EYE RESEARCH, 2020, 197
  • [4] Dendritic Cell Expression of Rictor (mTORC2), but Not Raptor (mTORC1), Protects Against Renal Ischemia-Reperfusion Injury
    Dai, H.
    Rogers, N.
    Watson, A.
    Fantus, D.
    Thomson, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 284 - 284
  • [5] DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells
    Cheng, Meijuan
    Lv, Xin
    Zhang, Cuihong
    Du, Wei
    Liu, Yaping
    Zhu, Lin
    Hao, Jun
    NEUROCHEMICAL RESEARCH, 2018, 43 (11) : 2141 - 2154
  • [6] DNMT1, a Novel Regulator Mediating mTORC1/mTORC2 Pathway-Induced NGF Expression in Schwann Cells
    Meijuan Cheng
    Xin Lv
    Cuihong Zhang
    Wei Du
    Yaping Liu
    Lin Zhu
    Jun Hao
    Neurochemical Research, 2018, 43 : 2141 - 2154
  • [7] Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid
    Chu, Ruth
    Zhao, Xiaoyue
    Griffin, Chandi
    Staub, Richard E.
    Shoemaker, Mark
    Climent, Joan
    Leitman, Dale
    Cohen, Isaac
    Shtivelman, Emma
    Fong, Sylvia
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (05) : 1209 - 1219
  • [8] mTORC1 inhibition with rapamycin leads to activation of PI3K/AKT signalling via an mTORC2 dependent mechanism in melanoma cells
    Werzowa, J.
    Pratscher, B.
    Cejka, D.
    Pehamberger, H.
    Wacheck, V.
    EJC SUPPLEMENTS, 2006, 4 (12): : 176 - 177
  • [9] Inhibition of mTORC2 but not mTORC1 Up-Regulates E-Cadherin Expression and Inhibits Cell Motility by Blocking HIF-2α Expression in Human Renal Cell Carcinoma
    Maru, Shintaro
    Ishigaki, Yasuhito
    Shinohara, Nobuo
    Takata, Takanobu
    Tomosugi, Naohisa
    Nonomura, Katsuya
    JOURNAL OF UROLOGY, 2013, 189 (05): : 1921 - 1929
  • [10] Correlation of PD-L1 and SOCS3 Co-expression with the Prognosis of Hepatocellular Carcinoma Patients
    Chen, Liuxi
    Huang, Xingxing
    Zhang, Wenzheng
    Liu, Ying
    Chen, Bi
    Xiang, Yu
    Zhang, Ruonan
    Zhang, Mingming
    Feng, Jiao
    Liu, Shuiping
    Duan, Ting
    Chen, Xiaying
    Wang, Wengang
    Pan, Ting
    Yan, Lili
    Jin, Ting
    Li, Guohua
    Li, Yongqiang
    Xie, Tian
    Sui, Xinbing
    JOURNAL OF CANCER, 2020, 11 (18): : 5440 - 5448
12345